Knight Therapeutics Inc.
KHTRF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $440,488 | $571,855 | $604,916 | $504,120 |
| - Cash | $58,787 | $77,816 | $112,155 | $80,106 |
| + Debt | $76,282 | $104,743 | $53,919 | $49,459 |
| Enterprise Value | $457,983 | $598,782 | $546,680 | $473,473 |
| Revenue | $87,271 | $107,358 | $88,076 | $96,864 |
| % Growth | -18.7% | 21.9% | -9.1% | – |
| Gross Profit | $28,981 | $44,831 | $34,866 | $40,352 |
| % Margin | 33.2% | 41.8% | 39.6% | 41.7% |
| EBITDA | $13,081 | -$1,098 | $12,941 | $24,292 |
| % Margin | 15% | -1% | 14.7% | 25.1% |
| Net Income | -$2,722 | -$12,622 | $2,185 | $10,735 |
| % Margin | -3.1% | -11.8% | 2.5% | 11.1% |
| EPS Diluted | -0.027 | -0.13 | 0.02 | 0.11 |
| % Growth | 79% | -750% | -81.8% | – |
| Operating Cash Flow | $7,578 | $20,252 | $3,670 | $1,469 |
| Capital Expenditures | -$294 | -$25,128 | -$3,701 | -$1,075 |
| Free Cash Flow | $7,283 | -$4,876 | -$31 | $394 |